Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter
email:    

Investor News

Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings

Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions
Start-Ups

IPO News
IPO


Clinical - Approvals
FDA Approves Eagle Pharmaceuticals (EGRX)' Ryanodex® For The Treatment Of Malignant Hyperthermia 7/23/2014 6:21:32 AM
U.S. Gilead Sciences, Inc. (GILD) Approves FDA's Zydelig® (idelalisib) For Relapsed Chronic Lymphocytic Leukemia, Follicular Lymphoma And Small Lymphocytic Lymphoma 7/23/2014 10:30:32 AM
Health Canada Approves Kane Biotech Inc. (KNE)'s DispersinB® For Human Use 7/23/2014 9:04:23 AM
Starpharma: VivaGel® Condom Receives TGA Device Certification - Launch Preparations To Follow 7/21/2014 8:23:12 AM
Pharming Group (PHGUF.PK), Salix Pharmaceuticals, Ltd. (SLXP) Wins FDA Approval For Ruconest® 7/17/2014 8:27:12 AM
Ion Beam Applications (IBA) Receives FDA Approval Of Its New Compact Gantry Clearing The Way For Proteus®ONE 7/16/2014 10:11:07 AM
MediWound (MDWD) Announces NexoBrid Marketing Approval From Israeli Ministry of Health 7/16/2014 5:52:35 AM
Hamilton Thorne, Inc. Receives Notification Of Grant Of Patent Right And CFDA Approval To Market Its LYKOS(R) Laser System In China 7/16/2014 10:23:32 AM
Purdue Pharma L.P. Receives FDA Approval For 7.5 Mcg/Hour Dosage Strength Of Butrans® (Buprenorphine) Transdermal System CIII 7/16/2014 9:21:44 AM
Octapharma USA, Inc. Announces FDA Approval Of Octagam 10%, Expanding Its Immune Globulin Therapy Portfolio 7/15/2014 9:09:24 AM
Medac Pharma, Inc. Wins FDA Approval Of Rasuvo Injection For Rheumatoid Arthritis, Poly-Articular-Course Juvenile Idiopathic Arthritis And Psoriasis 7/14/2014 7:02:28 AM
Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval Of APTIOM(TM) (eslicarbazepine acetate) As A Once-Daily Adjunctive Treatment For Partial-Onset Seizures In Patients With Epilepsy 7/11/2014 9:23:27 AM
Can-Fite BioPharma (CFBI)'s CF102 Approved For Compassionate Use In Israel For Liver Cancer Patient 7/10/2014 10:03:32 AM
Protein Sciences Corporation Receives Approval From FDA For 2014/15 Formulation Of Flublok® Influenza Vaccine 7/8/2014 10:46:04 AM
FDA Approves Anacor Pharmaceuticals, Inc. (ANAC)’ KERYDIN™ (Tavaborole) Topical Solution, 5% For The Treatment Of Onychomycosis Of The Toenails 7/8/2014 6:37:59 AM
1234567
//-->